DocSym
β
Searchsearch
Search
(Y47.0) Barbiturates, not elsewhere classified
More details coming soon
62 228 in individuals diagnosis barbiturates, not elsewhere classified confirmed
1 394 deaths with diagnosis barbiturates, not elsewhere classified
2% mortality rate associated with the disease barbiturates, not elsewhere classified
Diagnosis barbiturates, not elsewhere classified is diagnosed Women are 32.71% more likely than Men
20 937
Men receive the diagnosis barbiturates, not elsewhere classified
874 (4.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
41 291
Women receive the diagnosis barbiturates, not elsewhere classified
520 (1.3 %)Died from this diagnosis.
Risk Group for the Disease barbiturates, not elsewhere classified - Men aged 40-44 and Women aged 65-69
In Men diagnosis is most often set at age 0-24, 30-64, 70-74, 85-89
Less common in men the disease occurs at Age 0-1, 25-29, 65-69, 75-84, 90-95+Less common in women the disease occurs at Age 25-29, 70-74, 85-89, 95+
In Women diagnosis is most often set at age 0-24, 30-69, 75-84, 90-94
Disease Features barbiturates, not elsewhere classified
Absence or low individual and public risk
Barbiturates, not elsewhere classified - what does this mean
Barbiturates, not elsewhere classified are a group of sedative-hypnotic drugs that are used to treat anxiety, insomnia, and seizures. they work by depressing the central nervous system, slowing down brain activity and reducing the body's response to stress. they are highly addictive and can be dangerous if taken in large doses or in combination with other drugs. long-term use of barbiturates can lead to physical and psychological dependence.
What happens during the disease - barbiturates, not elsewhere classified
Barbiturates, not elsewhere classified, are a class of drugs that act on the central nervous system and can lead to sedation, sleep, and even coma. these medications are known to depress the activity of neurons in the brain, resulting in slowed breathing, decreased heart rate, and a decrease in overall blood pressure. long-term use of barbiturates can lead to dependence and tolerance, which can lead to an increased risk of overdose and death.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
9 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Barbiturates, not elsewhere classified - Prevention
The best way to prevent barbiturates, not elsewhere classified, is to avoid using them in the first place. if they are prescribed, it is important to follow the instructions of the doctor and take the medication as directed. avoiding excessive alcohol consumption, as well as other drugs, is also important for preventing this condition.